Wieczorek S - Search Results

1

NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington's Disease Network; Arning L. Saft C, et al. Among authors: wieczorek s. PLoS Curr. 2011 Oct 4;3:RRN1247. doi: 10.1371/currents.RRN1247. PLoS Curr. 2011. PMID: 21989477 Free PMC article.

2

Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.

Taherzadeh-Fard E, Saft C, Wieczorek S, Epplen JT, Arning L. Taherzadeh-Fard E, et al. Among authors: wieczorek s. Neurogenetics. 2010 Oct;11(4):435-9. doi: 10.1007/s10048-010-0248-3. Epub 2010 May 30. Neurogenetics. 2010. PMID: 20512606

3

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.

Arning L, Saft C, Wieczorek S, Andrich J, Kraus PH, Epplen JT. Arning L, et al. Among authors: wieczorek s. Hum Genet. 2007 Sep;122(2):175-82. doi: 10.1007/s00439-007-0393-4. Epub 2007 Jun 14. Hum Genet. 2007. PMID: 17569088

4

Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.

Arning L, Jagiello P, Wieczorek S, Saft C, Andrich J, Epplen JT. Arning L, et al. Among authors: wieczorek s. BMC Med Genet. 2004 Mar 24;5:7. doi: 10.1186/1471-2350-5-7. BMC Med Genet. 2004. PMID: 15040808 Free PMC article.

5

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.

Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L. Mai M, et al. Among authors: wieczorek s. BMC Med Genet. 2006 Nov 10;7:79. doi: 10.1186/1471-2350-7-79. BMC Med Genet. 2006. PMID: 17096834 Free PMC article.

6

ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.

Arning L, Monté D, Hansen W, Wieczorek S, Jagiello P, Akkad DA, Andrich J, Kraus PH, Saft C, Epplen JT. Arning L, et al. Among authors: wieczorek s. J Mol Med (Berl). 2008 Apr;86(4):485-90. doi: 10.1007/s00109-007-0299-6. Epub 2008 Mar 8. J Mol Med (Berl). 2008. PMID: 18327563

7

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.

Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L. Taherzadeh-Fard E, et al. Among authors: wieczorek s. Mol Neurodegener. 2011 May 19;6(1):32. doi: 10.1186/1750-1326-6-32. Mol Neurodegener. 2011. PMID: 21595933 Free PMC article.

8

Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.

Hansen W, Saft C, Andrich J, Müller T, Wieczorek S, Epplen JT, Arning L. Hansen W, et al. Among authors: wieczorek s. J Negat Results Biomed. 2005 Dec 22;4:12. doi: 10.1186/1477-5751-4-12. J Negat Results Biomed. 2005. PMID: 16372906 Free PMC article.

9

PGC-1alpha as modifier of onset age in Huntington disease.

Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L. Taherzadeh-Fard E, et al. Among authors: wieczorek s. Mol Neurodegener. 2009 Feb 6;4:10. doi: 10.1186/1750-1326-4-10. Mol Neurodegener. 2009. PMID: 19200361 Free PMC article.

10

Huntington's disease as caused by 34 CAG repeats.

Andrich J, Arning L, Wieczorek S, Kraus PH, Gold R, Saft C. Andrich J, et al. Among authors: wieczorek s. Mov Disord. 2008 Apr 30;23(6):879-81. doi: 10.1002/mds.21958. Mov Disord. 2008. PMID: 18307262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters